Pharmaceutical Executive October 24, 2025
Key Takeaways
- TrumpRx enables direct drug purchases from manufacturers, reducing prices and bypassing traditional pharmacy channels, enhancing patient access and communication.
- The DTC model aligns with Most-Favored-Nation pricing, aiming to close the US drug price gap with other high-income countries.
- Manufacturers must collaborate across marketing, policy, and market access teams to navigate the new DTC landscape and support stakeholders.
- Personalized, omnichannel marketing strategies are crucial for building trust and engagement, as traditional TV advertising faces potential restrictions.
The model imagines a new future in which traditional pharmacy distribution and access channels are bypassed.
In a year marked by an avalanche of unprecedented healthcare policy developments, the announcement of TrumpRx, a direct-to-consumer (DTC) drug distribution channel, is a defining...
Today's Sponsors
Today's Sponsor
Topics: Uncategorized